Cushman & Wakefield Limited CWK
13.62 USD -0.71 (-4.95%)
At closeNov 3, 2026, 4:00 PM EST
13.62 0.00 0.00%
After hours · Nov 3, 4:00 PM ET
13.62 Day range 14.46
10.88 52-week range 17.40
- YTD
- -15.87%
- 1 year
- -12.58%
Analyst view
Consensus: buy
Buy
Price target (mean) 16.36 +20.1% upside
Now 13.62
- Target (low)
- 13.00
- Target (mean)
- 16.36
- Target (high)
- 19.00
Ratings (0m) 12 7 buy · 5 hold · 0 sell
- Strong buy3
- Buy4
- Hold5
- Sell0
- Strong sell0
Recommendation trend
- This month 12
- 1 month ago 12
- 2 months ago 12
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.35656 | 0.33 – 0.38 | 0.29 | +23.0% | 2.79B | +7.1% | 12 |
| Next quarter | 0.59858 | 0.55 – 0.63 | 0.54 | +10.9% | 3.08B | +5.6% | 11 |
| Current year | 1.45 | 1.40 – 1.48 | 1.22 | +19.2% | 11.18B | +8.6% | 12 |
| Next year | 1.66 | 1.49 – 1.75 | 1.45 | +14.1% | 11.87B | +6.2% | 12 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 22, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 22, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Aug 17, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Aug 10, 2026 | UBS | Maintained | Neutral | Neutral |
| Mar 13, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Dec 2, 2025 | Barclays | Initiated | — | Equal-Weight |
| Nov 21, 2025 | Citigroup | Upgrade | Neutral | Buy |
| Nov 12, 2025 | Citigroup | Maintained | Neutral | Neutral |
| Nov 3, 2025 | Citizens | Maintained | Market Outperform | Market Outperform |
| Oct 10, 2025 | UBS | Maintained | Neutral | Neutral |
| Aug 26, 2025 | JP Morgan | Maintained | Neutral | Neutral |
| Aug 13, 2025 | Goldman Sachs | Maintained | Buy | Buy |
| Aug 8, 2025 | Goldman Sachs | Upgrade | Sell | Buy |
| Aug 6, 2025 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Jul 21, 2025 | JMP Securities | Initiated | — | Market Outperform |
| Jul 2, 2025 | UBS | Maintained | Neutral | Neutral |
| Jun 12, 2025 | Morgan Stanley | Maintained | Overweight | Overweight |
| Apr 24, 2025 | Morgan Stanley | Maintained | Overweight | Overweight |
| Apr 11, 2025 | UBS | Maintained | Neutral | Neutral |
| Apr 10, 2025 | JP Morgan | Maintained | Neutral | Neutral |
| Mar 19, 2025 | Goldman Sachs | Maintained | Sell | Sell |
| Mar 17, 2025 | Citigroup | Maintained | Neutral | Neutral |
| Feb 21, 2025 | Goldman Sachs | Maintained | Sell | Sell |
| Jan 2, 2025 | Jefferies | Downgrade | Buy | Hold |
| Dec 16, 2024 | JP Morgan | Maintained | Neutral | Neutral |
| Dec 6, 2024 | Goldman Sachs | Initiated | — | Sell |
| Jul 30, 2024 | JP Morgan | Maintained | Neutral | Neutral |
| Jul 25, 2024 | Raymond James | Maintained | Outperform | Outperform |
| Jun 21, 2024 | JP Morgan | Maintained | Neutral | Neutral |
| Apr 10, 2024 | Jefferies | Initiated | — | Buy |
